We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$248M
AUM Growth
-$83M
Cap. Flow
-$106M
Cap. Flow %
-42.96%
Top 10 Hldgs %
75.81%
Holding
46
New
2
Increased
4
Reduced
7
Closed
22

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$13.5M
2
MLCO icon
Melco Resorts & Entertainment
MLCO
+$9.28M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.95M
4
LBRT icon
Liberty Energy
LBRT
+$2.99M
5
MDU icon
MDU Resources
MDU
+$2.88M

Top Sells

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$15.1M
2
ALC icon
Alcon
ALC
+$11.3M
3
HUM icon
Humana
HUM
+$10.2M
4
AVAN.U
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
+$10M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$9.49M

Sector Composition

Rank Sector Weight
1 Technology 27.59%
2 Healthcare 21.32%
3 Consumer Discretionary 13.88%
4 Financials 12.96%
5 Communication Services 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
26
AstraZeneca
AZN
$264B
– –
-78,200
Closed -$8.58M
BPMC
27
DELISTED
Blueprint Medicines
BPMC
– –
-53,300
Closed -$3.51M
CNC icon
28
Centene
CNC
$30.8B
– –
-28,263
Closed -$2.2M
HUM icon
29
Humana
HUM
$43.8B
– –
-21,000
Closed -$10.2M
IRTC icon
30
iRhythm Holdings
IRTC
$3.88B
– –
-120,879
Closed -$15.1M
IRWD icon
31
Ironwood Pharmaceuticals
IRWD
$695M
– –
-916,314
Closed -$9.49M
LIVN icon
32
LivaNova
LIVN
$4.43B
– –
-26,790
Closed -$1.36M
MSOS icon
33
AdvisorShares Pure US Cannabis ETF
MSOS
$862M
– –
-55,958
Closed -$499K
NAUT icon
34
Nautilus Biotechnolgy
NAUT
$125M
– –
-413,700
Closed -$877K
PRVA icon
35
Privia Health
PRVA
$2.99B
– –
-47,703
Closed -$1.63M
QTRX icon
36
Quanterix
QTRX
$166M
– –
-198,600
Closed -$2.19M
RXST icon
37
RxSight
RXST
$248M
– –
-221,732
Closed -$2.66M
SKIN icon
38
SkinHealth Systems
SKIN
$87.2M
– –
-446,607
Closed -$5.26M
STAA icon
39
STAAR Surgical
STAA
$1.21B
– –
-46,536
Closed -$3.28M
XENE icon
40
Xenon Pharmaceuticals
XENE
$6.11B
– –
-45,235
Closed -$1.63M
RCM
41
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-374,800
Closed -$6.95M
NEXI
42
DELISTED
NexImmune, Inc. Common Stock
NEXI
– –
-16,000
Closed -$222K
DMTK
43
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-208,600
Closed -$826K
KRTX
44
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-28,600
Closed -$6.43M
ABCM
45
DELISTED
Abcam PLC
ABCM
– –
-142,350
Closed -$2.13M
AVAN.U
46
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
– –
-1,000,000
Closed -$10M
1
2

Similar funds

SHFC
Safe Harbor Family Capital Chapel Hill, North Carolina $128M AUM
IUC
Ivory Union Consulting Road Town $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $128M AUM 44.06% 1-Year Est. Return
S
Storgate Dallas, Texas $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Bridger Management's Q4 2022 Portfolio in Review

As of Q4 2022, Bridger Management held 46 positions worth $248M, down 25% from $331M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bridger Management withdrew a net $106M in Q4 2022, closing 22 positions and reducing 7 holdings. Its most notable exit was iRhythm Holdings, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bridger Management opened a new position in Biogen worth $13.2M.

  • Bridger Management's largest Q4 2022 buy was Biogen: 47,777 shares worth $13.2M.
  • Bridger Management added most to Melco Resorts & Entertainment in Q4 2022, an estimated $9.28M increase.
  • Bridger Management's biggest Q4 2022 reduction was Alcon, cutting an estimated $11.3M.
  • Bridger Management fully exited iRhythm Holdings in Q4 2022, selling an estimated $15.1M.
  • Bridger Management's ten largest holdings make up 76% of its $248M portfolio in Q4 2022.
  • Bridger Management opened 2 new positions and closed 22 in Q4 2022.
  • Bridger Management's portfolio value fell 25% quarter-over-quarter to $248M.

Based on Bridger Management's 13F filing for Q4 2022, filed 15 Feb 2023.